Tech Company Financing Transactions
TECLens Funding Round
TECLens secured a $9.3 million Series A financing round on 2/11/2025. Investors included Johnson & Johnson Innovation, Yonjin Venture and Sunmed Capital.
Transaction Overview
Company Name
Announced On
2/11/2025
Transaction Type
Venture Equity
Amount
$9,300,000
Round
Series A
Investors
Proceeds Purpose
The funding is allocated to support the clinical development of the company's non-incisional refractive correction procedure that leverages corneal cross-linking (CXL) to reshape the cornea.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
9 Riverbend Dr. South
Stamford, CT 06907
USA
Stamford, CT 06907
USA
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
At TECLens, we are dedicated to transforming the future of vision care by pioneering non-invasive, personalized corneal crosslinking treatments. Our breakthrough qCXL� technology aims to set a new standard in precision, accessibility, and patient experience--redefining vision correction with innovation that improves quality of life.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Tom Dunlap
Chief Operating Officer
Patrick Lopath
Browse more venture capital transactions:
Prev: 2/11/2025: Coral venture capital transaction
Next: 2/11/2025: Levee Medical venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to report on all VC transactions involving tech companies. VC investment data records on this site are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs